Crossmark

DMPP attenuates lipopolysaccharide-induced lung injury by inhibiting glycocalyx degradation through activation of the cholinergic anti-inflammatory pathway

Crossref DOI link: https://doi.org/10.1007/s10863-023-09989-0

Published Online: 2023-10-18

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qi, Feng

Duan, Chengwei

Chen, Tianpeng

Li, Feng

Zhang, Jinsong
Funding

Funding for this research was provided by:

Nantong Health and Wellness Commission (MB2019012, MB2019012, MB2019012, MB2019012, MB2019012)

Nantong Science and Technology Bureau (HS2018002, HS2018002, HS2018002, HS2018002, HS2018002)
License Information

Text and Data Mining valid from 2023-10-18

Version of Record valid from 2023-10-18
More Information

Article History

Received: 4 September 2023

Accepted: 11 October 2023

First Online: 18 October 2023

Declarations

:

: The animal study procedures were approved by the Animal Experiment Ethics Committee of Nantong University (Approval No. S20220210-002). All animal housing and animal experiments were carried out in accordance with the ARRIVE guidelines.

: Not applicable.

: The authors declare no competing interests.

: The authors declare that there is no conflict of interest.

Document is current

Any future updates will be listed below